|
C5ORF45 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.023680E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.418600E-04 |
| Normal-vs-Stage2 |
1.709410E-01 |
| Normal-vs-Stage3 |
8.889600E-01 |
| Normal-vs-Stage4 |
1.928020E-01 |
| Stage1-vs-Stage2 |
8.802000E-01 |
| Stage1-vs-Stage3 |
3.541500E-03 |
| Stage1-vs-Stage4 |
8.187600E-01 |
| Stage2-vs-Stage3 |
1.658560E-01 |
| Stage2-vs-Stage4 |
9.687400E-01 |
| Stage3-vs-Stage4 |
1.862750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.829690E-04 |
| Normal-vs-AfricanAmerican |
1.375580E-01 |
| Normal-vs-Asian |
6.719400E-01 |
| Caucasian-vs-AfricanAmerican |
5.817800E-01 |
| Caucasian-vs-Asian |
6.669400E-01 |
| AfricanAmerican-vs-Asian |
5.394000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.638200E-04 |
| Normal-vs-Female |
1.104820E-01 |
| Male-vs-Female |
5.922000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.479800E-02 |
| Normal-vs-Extreme_Weight |
1.978800E-04 |
| Normal-vs-Obese |
1.402450E-01 |
| Normal-vs-Extreme_Obese |
2.589000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.989400E-01 |
| Normal_Weight-vs-Obese |
5.861200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.116800E-01 |
| Extreme_Weight-vs-Obese |
8.649800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.228000E-01 |
| Obese-vs-Extreme_Obese |
9.540600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.725800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.017200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.455500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.916600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.146200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.530000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.471000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.463200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.975800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.909000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.69370000047931E-07 |
| Normal-VS-Type2 PRCC |
2.759200E-01 |
| Normal-VS-KIRP CIMP |
6.018500E-03 |
| Normal-VS-Unclassified PRCC |
1.697040E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.540000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.67029999726043E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
1.369160E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.119900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.277400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.357400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.277700E-02 |
| Normal-vs-N1 |
5.177200E-01 |
| Normal-vs-N2 |
9.923000E-01 |
| N0-vs-N1 |
3.347800E-01 |
| N0-vs-N2 |
5.037800E-01 |
| N1-vs-N2 |
7.901600E-01 |
|
|
